Jump Trading’s Epizyme, Inc EPZM Stock Holding History

Jump Trading’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-14,100	Closed	-$175K	–	645
2019 Q1	$175K	Buy	+14,100	New	+$158K	0.06%	405

Other funds holding EPZM

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Jump Trading's EPZM Position: Q2 2019 in Review

Jump Trading sold out of Epizyme, Inc (EPZM) in Q2 2019, closing a stake of 14,100 shares — an estimated $175K sold.

Jump Trading first reported a position in EPZM in Q1 2019 and held it in 1 quarter. The position peaked at $175K in Q1 2019. 134 funds tracked by Wall St. Rank hold EPZM as of Q2 2019.

Jump Trading reported no remaining Epizyme, Inc position as of Q2 2019 after selling out during the quarter.
Jump Trading sold 14,100 Epizyme, Inc shares in Q2 2019, an estimated $175K.
Jump Trading first reported a position in Epizyme, Inc in Q1 2019 and held it in 1 quarter.
Jump Trading's Epizyme, Inc position peaked at $175K in Q1 2019.
134 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2019.

Based on Jump Trading's 13F filing for Q2 2019, filed 14 Aug 2019.